Does N-Acetylcysteine Decrease Spontaneous Oxidation of Central Neural Dopamine in Parkinson's Disease?

PHASE1

Phase

TERMINATED

Status

Enrollment

NIH

Sponsor class

Stopped Difficulty with recruitment and participant accrual due to study eligibility criteria and required study procedures (e.g., multiple lumbar punctures).

Conditions

Parkinson Disease
Cerebrospinal Fluid

Interventions

DRUG: N-Acetylcysteine
PROCEDURE: Lumbar Puncture
RADIATION: Fluoroscopy

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)